Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
epclusa
gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 og 5.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
atorker 10 mg filmovertrukne tabletter
medochemie ltd. - atorvastatincalcium - filmovertrukne tabletter - 10 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
atorker 20 mg filmovertrukne tabletter
medochemie ltd. - atorvastatincalcium - filmovertrukne tabletter - 20 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
atorker 40 mg filmovertrukne tabletter
medochemie ltd. - atorvastatincalcium - filmovertrukne tabletter - 40 mg
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
ztalmy
marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - andre antiepileptika - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
olysio
janssen-cilag international nv - simeprevir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - olysio er indiceret i kombination med andre lægemidler til behandling af kronisk hepatitis c (chc) hos voksne patienter. for at hepatitis c virus (hcv) genotype specifikke aktivitet.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
alcartis 10 mg smeltetabletter
egis pharmaceuticals plc - aripiprazol - smeltetabletter - 10 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
alcartis 15 mg smeltetabletter
egis pharmaceuticals plc - aripiprazol - smeltetabletter - 15 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
alcartis 30 mg smeltetabletter
egis pharmaceuticals plc - aripiprazol - smeltetabletter - 30 mg